Prashant Raj Singh

Prashant Raj Singh

Auto-generated profile, based on publicly available information

Prashant Raj Singh

Laboratory of Photobiology and Molecular Microbiology, Centre of Advanced Study in Botany, Institute of Science, Banaras Hindu University, Varanasi, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2023 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
ASAshish P. Singh
Ashish P. Singh
AMIT GUPTAAMIT GUPTA
AMIT GUPTA
PSPrashant R. Singh
Prashant R. Singh
JJJyoti Jaiswal
Jyoti Jaiswal
RSRajeshwar Sinha
Rajeshwar Sinha

25 May 2023 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
PSPrashant R. Singh
Prashant R. Singh
JPJainendra Pathak
Jainendra Pathak
RARajneesh
Rajneesh
HAHaseen Ahmed
Haseen Ahmed
DHDonat Häder
Donat Häder
RSRajeshwar Sinha
Rajeshwar Sinha

1 December 2023 in Current Protein & Peptide Science
Verified
Journal Article
Closed access
PDF file
AMIT GUPTAAMIT GUPTA
AMIT GUPTA
PSPrashant Raj Singh
Prashant Raj Singh
ASAshish Pratap Singh
Ashish Pratap Singh
NKNeha Kumari
Neha Kumari
JJJyoti Jaiswal
Jyoti Jaiswal
RSRajeshwar Sinha
Rajeshwar Sinha
Cyanobacteria have been recognized as a rich source of bioactive metabolites with potential biotechnological applications in the pharmacological industry. The chemically diverse natural compounds or their analogues cause cytotoxicity. They may kill various cancer cells by inducing apoptosis or changing the activation of cell signaling, particularly involving the protein kinase-C family of enzymes, mitochondrial dysfunctions, and oxidative damage. B cell lymphoma 2 (Bcl-2) is an essential component of apoptosis and is an antiapoptotic molecule. The key apoptotic regulators associated with cancer are members of the Bcl-2 protein family, the key member of which is Bcl-2. The Bcl-2 protein is a promising target for the emergence of new anti-tumor therapies because of its critical role in controlling apoptosis. This review explores the significance of Bcl-2 in the onset of cancer; it may be used as a target for developing high-quality drug therapies to treat various tumors. In addition, a number of computational techniques were used to identify novel hit compounds that may act as inhibitors of the apoptotic protein Bcl-2, including virtual screening, toxicity prediction, and drug-likeness analysis. Twenty-three compounds were assessed as potential hits against Bcl-2, and these compounds were subjected to ADMET property prediction. Dendroamide A and Welwitindolinone A appear to be the most stable and effective drugs against Bcl-2 out of all those evaluated. This article gives an overview of the bioactive compounds produced by cyanobacteria that have anticancer properties and may be exploited to create novel anticancer medications in the future.


13 June 2025 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
PSPrashant R. Singh
Prashant R. Singh
ASAshish P. Singh
Ashish P. Singh
AMIT GUPTAAMIT GUPTA
AMIT GUPTA
Shailendra pratap SinghShailendra pratap Singh
Shailendra pratap Singh
RSRajeshwar Sinha
Rajeshwar Sinha

11 August 2026 in Journal of Plant Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
JJJyoti Jaiswal
Jyoti Jaiswal
AMIT GUPTAAMIT GUPTA
AMIT GUPTA
ASAshish P. Singh
Ashish P. Singh
NKNeha Kumari
Neha Kumari
PSPrashant R. Singh
Prashant R. Singh
RSRajeshwar Sinha
Rajeshwar Sinha